Dermatological indications for the use of isotretinoin beyond acne

被引:15
|
作者
Forbat, Emily [1 ]
Ali, Faisal R. [2 ]
Al-Niaimi, Firas [2 ]
机构
[1] Chelsea & Westminster Hosp, 369 Fulham Rd, London SW10 9NH, England
[2] Guys & St Thomas NHS Fdn Trust, Guys Canc Ctr, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, London, England
关键词
Isotretinoin; retinoids; rosacea; cosmetic dermatology; hidradenitis suppurativa; LOW-DOSE ISOTRETINOIN; INDUCED SEBACEOUS HYPERPLASIA; PLACEBO-CONTROLLED TRIAL; SQUAMOUS-CELL CARCINOMA; SKIN-CANCER PREVENTION; ORAL ISOTRETINOIN; SYSTEMIC ISOTRETINOIN; HIDRADENITIS SUPPURATIVA; PRURIGO PIGMENTOSA; PSORIASIS-VULGARIS;
D O I
10.1080/09546634.2018.1445194
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
While the use of isotretinoin has revolutionized the treatment of acne vulgaris, isotretinoin is increasingly recognized as a useful therapeutic option for many other cutaneous conditions. We review the evidence underlying the use of isotretinoin for a variety of dermatological indications including hidradenitis suppurativa, sebaceous gland pathology, rosacea, scarring alopecia, cosmetic dermatology, and non-melanoma skin cancer prophylaxis amongst other uses, and thus consider alternative uses within dermatology practice. The studies found benefit of isotretinoin, however most trials lacked statistical power and in many cases the use was limited to case series. Isotretinoin, if used within the correct cohort with appropriate pretreatment counseling regarding side-effects, is a well-tolerated medication with potential as either an adjunctive treatment or a second-line agent in those recalcitrant cases unresponsive to first-line therapy.
引用
收藏
页码:698 / 705
页数:8
相关论文
共 50 条
  • [1] Oral isotretinoin: beyond acne - a review of its use in cosmesis
    Mok, Z. R.
    Aw, D. C. W.
    [J]. HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2015, 23 (02): : 62 - 68
  • [2] The use of isotretinoin in acne
    Layton, Alison
    [J]. DERMATO-ENDOCRINOLOGY, 2009, 1 (03) : 162 - 169
  • [3] Use of Isotretinoin for Acne Vulgaris
    Merritt, Bradley
    Burkhart, Craig N.
    Morrell, Dean S.
    [J]. PEDIATRIC ANNALS, 2009, 38 (06): : 311 - 320
  • [4] Non-acne dermatologic indications for systemic isotretinoin
    Akyol, M
    Özçelik, S
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2005, 6 (03) : 175 - 184
  • [5] Non-Acne Dermatologic Indications for Systemic Isotretinoin
    Melih Akyol
    Sedat Özçelik
    [J]. American Journal of Clinical Dermatology, 2005, 6 : 175 - 184
  • [6] CURRENT INDICATIONS FOR ISOTRETINOIN AS A TREATMENT FOR ACNE-VULGARIS
    GOULDEN, V
    LAYTON, AM
    CUNLIFFE, WJ
    [J]. DERMATOLOGY, 1995, 190 (04) : 284 - 287
  • [7] GUIDELINES FOR OPTIMAL USE OF ISOTRETINOIN IN ACNE
    LAYTON, AM
    CUNLIFFE, WJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (06) : S2 - S7
  • [8] Use of thalidomide in dermatological indications
    Kontogiannis, V
    Powell, RJ
    [J]. BIODRUGS, 2000, 13 (04) : 255 - 265
  • [9] Use of Thalidomide in Dermatological Indications
    Vlassis Kontogiannis
    Richard J. Powell
    [J]. BioDrugs, 2000, 13 : 255 - 265
  • [10] Challenges in Optimizing Isotretinoin Use for Acne Vulgaris
    McIntee, Thomas J.
    Bruckner, Anna L.
    [J]. JAMA DERMATOLOGY, 2013, 149 (12) : 1398 - 1399